These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 4769664)
1. [Immune response after intramuscular administration of vaccinia virus]. Wurzel R Cesk Pediatr; 1973 Nov; 28(11):612-5. PubMed ID: 4769664 [No Abstract] [Full Text] [Related]
2. [Relation between antibody formation and immunity against cutaneous vaccinia virus infection in hens]. Andrzejewski J; Bogunowicz A; Zajac I Zentralbl Bakteriol Orig; 1968; 207(3):419-21. PubMed ID: 5745681 [No Abstract] [Full Text] [Related]
3. Differences between extracellular and intracellular forms of poxvirus and their implications. Boulter EA; Appleyard G Prog Med Virol; 1973; 16():86-108. PubMed ID: 4356899 [No Abstract] [Full Text] [Related]
4. Neutralizing antibody in the respiratory tract of chickens inoculated with Newcastle disease vaccines. Yoshida I; Oka M; Shimizu F; Yuasa N; Tsubahara H Natl Inst Anim Health Q (Tokyo); 1971; 11(2):75-82. PubMed ID: 5569700 [No Abstract] [Full Text] [Related]
5. Antibody in tears following intranasal vaccination with inactivated virus. II. Enhancement of tear antibody production by the use of polyinosinic: polycytidilic acid (poly I:C). Knopf HL; Blacklow NR; Glassman MI; Cline WL; Wong VG Invest Ophthalmol; 1971 Oct; 10(10):750-9. PubMed ID: 4941859 [No Abstract] [Full Text] [Related]
6. The immunogenicity of heat-inactivated vaccinia virus in rabbits. Madeley CR J Hyg (Lond); 1968 Mar; 66(1):89-107. PubMed ID: 4967145 [No Abstract] [Full Text] [Related]
7. [The effectiveness of immunization with vaccinia virus type "MVA" against an infection with cowpox virus type "OPV 85" in rabbits]. Munz E; Linckh S; Renner-Müller IC; Reimann M Zentralbl Veterinarmed B; 1993 Mar; 40(2):131-40. PubMed ID: 8322545 [TBL] [Abstract][Full Text] [Related]
8. The immunity to vaccina virus of Japanese people of different age groups: serum antibody titre and local skin reaction at the site of vaccination. Kitaoka M; Nishimura C; Kimura M Prog Immunobiol Stand; 1970; 4():683-91. PubMed ID: 5482206 [No Abstract] [Full Text] [Related]
10. Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses. Huang X; Liu L; Ren L; Qiu C; Wan Y; Xu J Vaccine; 2007 Dec; 25(52):8874-84. PubMed ID: 18061316 [TBL] [Abstract][Full Text] [Related]
11. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge. Pulford DJ; Gates A; Bridge SH; Robinson JH; Ulaeto D Vaccine; 2004 Sep; 22(25-26):3358-66. PubMed ID: 15308360 [TBL] [Abstract][Full Text] [Related]
12. Effect of food and water deprivation of chickens prior to exposure to Newcastle disease virus. Spalatin J; Hanson RP Avian Dis; 1974 Jul; 18(3):326-30. PubMed ID: 4851642 [No Abstract] [Full Text] [Related]
13. Studies on different strains of vaccinia virus with particular reference to their quality regarding immunogenicity and reactogenicity. 3. Studies in rabbits and monkeys (Macaca mulatta). Sehgal CL; Suri NK; Choudhury S; Murty DK; Raghavan NG Indian J Med Res; 1973 Sep; 61(9):1265-74. PubMed ID: 4205143 [No Abstract] [Full Text] [Related]
14. Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity. He Y; Manischewitz J; Meseda CA; Merchlinsky M; Vassell RA; Sirota L; Berkower I; Golding H; Weiss CD J Infect Dis; 2007 Oct; 196(7):1026-32. PubMed ID: 17763325 [TBL] [Abstract][Full Text] [Related]
15. [Approach to the development of an actovaccine using vaccinia virus as a model]. Chimishkian KL; Svet-Moldavskiĭ GIa Vopr Virusol; 1975; (3):273-8. PubMed ID: 1162946 [TBL] [Abstract][Full Text] [Related]
16. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing. Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675 [TBL] [Abstract][Full Text] [Related]
17. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals. Lodmell DL; Esposito JJ; Ewalt LC Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356 [TBL] [Abstract][Full Text] [Related]
18. Protective effect of newcastle disease vaccine against respiratory infection of chickens. Yoshida I; Oka M; Matsuda K; Yuasa N; Tsubahara H Natl Inst Anim Health Q (Tokyo); 1971; 11(4):173-83. PubMed ID: 5142163 [No Abstract] [Full Text] [Related]
19. Immune response of pups to modified live-virus canine distemper-measles vaccine. Brown AL; Vitamvas JA; Merry DL; Beckenhauer WH Am J Vet Res; 1972 Jul; 33(7):1447-56. PubMed ID: 5039517 [No Abstract] [Full Text] [Related]
20. Mucosal or systemic administration of rE2 glycoprotein antigen loaded PLGA microspheres. Brandhonneur N; Loizel C; Chevanne F; Wakeley P; Jestin A; Le Potier MF; Le Corre P Int J Pharm; 2009 May; 373(1-2):16-23. PubMed ID: 19429284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]